Drugs / Trazodone Prolonged Release
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03852160 Background | Dec 2019 → Jul 2021 | major depressive disorder | Janssen-Cilag International NV | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trazodone Prolonged Release | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03852160 ↗ |
| Route | Oral | “oral antidepressant medication” NCT03852160 ↗ |